Complications in patients with cardiogenic shock on veno-arterial extracorporeal membrane oxygenation therapy: distribution and relevance. Results from an international, multicentre cohort study.
Benedikt N BeerCaroline KellnerAlina GoßlingJonas SundermeyerLisa BeschAngela DettlingPaulus F KirchhofStefan BlankenbergAlexander M BernhardtStefan BrunnerPascal ColsonDennis EcknerDerk FrankIngo EitelNorbert FreyMatthias EdenTobias GrafDanny KupkaUlf LandmesserNicolas MajunkeOctavian ManiucSven Möbius-WinklerDavid A MorrowMarc MouradCurt NoelPeter NordbeckMartin OrbanFederico PappalardoSandeep M PatelMatthias PauschingerHermann ReichenspurnerP Christian SchulzeRobert H G SchwingerAntonia WechslerCarsten SkurkHolger ThieleAnubodh S VarshneyCan Martin SagJannis KraisDirk WestermannBenedikt SchragePublished in: European heart journal. Acute cardiovascular care (2023)
Therapy and device-related complications occur in half of all patients treated with VA-ECMO and are associated with a worse prognosis. They accumulate in some patients, especially in women. Aside from neurological events, identification of patients at risk is difficult, highlighting the need to establish additional quantitative markers of complication risk to guide VA-ECMO treatment in CS.
Keyphrases
- extracorporeal membrane oxygenation
- acute respiratory distress syndrome
- end stage renal disease
- ejection fraction
- chronic kidney disease
- newly diagnosed
- respiratory failure
- prognostic factors
- peritoneal dialysis
- randomized controlled trial
- high resolution
- intensive care unit
- stem cells
- mass spectrometry
- pregnant women
- mechanical ventilation
- patient reported outcomes
- cross sectional
- bone marrow
- metabolic syndrome
- subarachnoid hemorrhage
- smoking cessation
- pregnancy outcomes
- cervical cancer screening